CLINICAL STUDIES OF TA-058
1984 Volume 32 Issue Supplement2 Pages 225-229
Details
1984 Volume 32 Issue Supplement2 Pages 225-229
A new antibiotic TA-058 was studied in the clinic, and the following results were obtained.
TA-058 was administered to 14 patients: 12 respiratory tract infections, 2 urinary tract infections.
TA-058 was given intravenously in all cases at a daily dose 2.0g or 4.0 g to the patients.
Clinical response was good in 10 patients, and poor in 4.
Diarrhea occured in one patient, but it was able to continue the administration of TA-058 with the antidiarrheal agents. Although laboratory tests revealed the elevation of Al-P in one patient, this finding alleviated rapidly following cessation of the therapy. No severe side effects caused by the drug were observed.
